Scoring treatment response in patients with relapsing multiple sclerosis.

The article presents a study on the assessing treatment response of patients with multiple sclerosis (MS) through clinical and magnetic resonance imaging (MRI). It mentions that two datasets of relapsing-remitting multiple sclerosis (RRMS) patients were used, in which one set had 373 RRMS patients treated with subcutaneous interferon beta-1a and the other one with 222 patients treated with different interferons. It adds that the result of the study can help in the decision making of clinicians.